Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Five (Non-COVID) Clinical Trial Misses Of 2021

Jan 18 2022

• By Alexandra Shimmings

Miss a goal — Not all shots on goal are successful • Source: Alamy

Related Content

Gene Therapy: AAV Doses Should Not Be Subject To Fixed Upper Limit, US FDA Panel Says

Sep 09 2021

Sarepta Sinks On Mixed DMD Gene Therapy Study

Jan 08 2021

Ziritaxestat Failure Could Spell End For Gilead/Galapagos Pact

Feb 11 2021

Lung Cancer Failure Isn't The End For Merck KGaA And GSK's Bintrafusp

Jan 21 2021

Pfizer DMD Gene Therapy Phase III Trial Faces A US Delay; Can Sarepta Close The Gap?

May 05 2021

Astellas Pauses XLMTM Gene Therapy Trial After Another Safety Scare

Sep 01 2021

Roche Jumps Back Into Huntington’s With Spark/NeuExcell Partnership

Sep 07 2021

BioMarin Trial Halt Raises Another Safety Flag On AAV Gene Therapy

Sep 06 2021

GSK Exits $4.2bn Cancer Drug Deal With Merck KGaA After Multiple Failures

Oct 01 2021

Novartis Hopes For Canakinumab In Lung Cancer Nosedive

Oct 25 2021

Can Sarepta Beat Pfizer To A Duchenne Gene Therapy Breakthrough?

Oct 15 2021

New Player Joins Search For Effective Huntington's Therapies

Nov 26 2021

Toledo Data Fail To Give Galapagos A Lift

Jul 15 2021

Roche Shelves Phase III Huntington's Candidate Tominersen

Mar 23 2021

Wave’s Huntington Drugs Wipe Out As Trials Run Aground

Mar 30 2021

Novartis Hit By Canakinumab NSCLC Miss

Mar 09 2021

Related Companies

Merck KGaA

GSK plc

Roche Holding AG

Ionis Pharmaceuticals, Inc.

Wave Life Sciences Ltd.

Galapagos NV

Gilead Sciences, Inc.

Novartis AG

Sarepta Therapeutics, Inc.

Pfizer Inc.

Nightstar Therapeutics plc

Astellas Pharma, Inc.

Additional Topics

Clinical Trials Companies Innovation Research & Development Gene Therapy Cancer Liver & Hepatic Metabolic Disorders BioPharmaceutical

More from Innovation

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window